Cedar Mountain Advisors’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.5K | Buy |
245
+2
| +0.8% | +$372 | 0.01% | 105 |
|
|
2025
Q1 | $50.9K | Buy |
243
+2
| +0.8% | +$419 | 0.01% | 93 |
|
|
2024
Q4 | $42.8K | Buy |
241
+2
| +0.8% | +$355 | 0.01% | 99 |
|
|
2024
Q3 | $47.2K | Buy |
239
+2
| +0.8% | +$395 | 0.01% | 86 |
|
|
2024
Q2 | $40.7K | Sell |
237
-9
| -4% | -$1.54K | 0.01% | 85 |
|
|
2024
Q1 | $44.8K | Buy |
246
+2
| +0.8% | +$364 | 0.01% | 78 |
|
|
2023
Q4 | $37.8K | Buy |
244
+13
| +6% | +$2.02K | 0.01% | 86 |
|
|
2023
Q3 | $34.4K | Buy |
231
+2
| +0.9% | +$298 | 0.01% | 86 |
|
|
2023
Q2 | $30.8K | Buy |
229
+22
| +11% | +$2.96K | 0.01% | 95 |
|
|
2023
Q1 | $32.9K | Sell |
207
-78
| -27% | -$12.4K | 0.01% | 90 |
|
|
2022
Q4 | $46K | Buy |
285
+2
| +0.7% | +$323 | 0.01% | 75 |
|
|
2022
Q3 | $38K | Buy |
283
+2
| +0.7% | +$269 | 0.01% | 80 |
|
|
2022
Q2 | $43K | Buy |
281
+2
| +0.7% | +$306 | 0.01% | 78 |
|
|
2022
Q1 | $45K | Buy |
279
+2
| +0.7% | +$323 | 0.01% | 81 |
|
|
2021
Q4 | $38K | Buy |
277
+2
| +0.7% | +$274 | 0.01% | 89 |
|
|
2021
Q3 | $30K | Buy |
275
+82
| +42% | +$8.95K | 0.01% | 98 |
|
|
2021
Q2 | $22K | Buy |
193
+2
| +1% | +$228 | 0.01% | 109 |
|
|
2021
Q1 | $21K | Buy |
191
+3
| +2% | +$330 | 0.01% | 126 |
|
|
2020
Q4 | $20K | Buy |
188
+2
| +1% | +$213 | 0.01% | 120 |
|
|
2020
Q3 | $16K | Buy |
186
+2
| +1% | +$172 | 0.01% | 117 |
|
|
2020
Q2 | $18K | Buy |
184
+2
| +1% | +$196 | 0.01% | 105 |
|
|
2020
Q1 | $14K | Buy |
182
+3
| +2% | +$231 | 0.01% | 102 |
|
|
2019
Q4 | $16K | Buy |
+179
| New | +$16K | 0.01% | 114 |
|